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Abstract: Aflatoxins (AFs) are mycotoxins produced by some species of Aspergillus. In dairy cows,
ingested AFB1 is metabolized into carcinogenic AFM1 which is eliminated through milk, thus posing
a risk for consumer health. Here we describe the set, validation, and application of screening (ELISA)
and confirmatory (HPLC) tests carried out on milk samples collected through official control of
mycotoxin levels in northern Italy over a three-year period (2012–2014). The limit of detection (LOD)
was set at 5 ppt (ng/kg) and 2 ppt for ELISA and HPLC, respectively, and the limit of quantification
(LOQ) was 10 ppt for confirmatory HPLC. A total of 1668 milk samples were analyzed: ELISA
identified 36 (2.2%) positive milk samples that were subsequently confirmed by HPLC. The level of
AFM1 in the positive samples ranged between 18 ˘ 2 and 208 ˘ 27 ppt. Of the total samples, only
eight (0.5%) were found non-compliant with the EU regulatory limit (50 ppt; range 74 ˘ 10 to 208
˘ 27 ppt). Use of ELISA and HPLC tests in series allows for high-volume analysis of samples, thus
saving time and money while guaranteeing high analytical precision and accuracy.
Keywords: aflatoxin M1; milk; food safety
1. Introduction
Many genera of molds growing on agricultural products produce toxic substances, generally
called mycotoxins: some have mutagenic or carcinogenic effects, others are toxic for specific organs,
and others still pose health risks owing to the effects they can have on an organism (e.g., vomiting or
immunodeficiency) [1].
Mycotoxins are secondary metabolites of various different fungal species and they differ in
chemical structure, biosynthetic origins, and biological effects. Clinicians classify mycotoxins as
hepatotoxins, nephrotoxins, neurotoxins, immunotoxins, and so forth, whereas cell biologists classify
them as teratogens, mutagens, carcinogens, and allergens. Aflatoxin, for example, is a hepatotoxic,
mutagenic, carcinogenic, polyketide-derived Aspergillus mycotoxin [2]. Of the over 300 types of
mycotoxins identified so far, aflatoxins (AFs) are the most extensively studied and one of most
important classes from a public health perspective [3]. AFs figure among the most serious and
well-known naturally occurring toxins in food and feed, with AFB1 being the most toxic and
carcinogenic [4].
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The first AFs were discovered in England in 1961 when a severe outbreak of turkey “X” disease
resulted in the death of more than 100,000 birds. Peanut meal feed contaminated with a toxin produced
by a filamentous fungus was found to be the source of the outbreak [5]. AFs are mainly produced by
fungi of the genus Aspergillus (particularly A. flavus, A. parasiticus and rarely A. nomius) [6]. About
20 AFs belong to a larger group of toxic compounds called di-furanocoumarins, only four of which
(AFB1, AFG1, AFB2, and AFG2) naturally contaminate foods. The hydroxymetabolites aflatoxin M1
(AFM1) and aflatoxin M2 (AFM2) can be present in milk and milk products when lactating cows or
other mammals ingest contaminated feed [7]. It is estimated that about 1%–3% [8] to 6% [9] of AFB1 in
feed is present as AFM1 in milk from within a few hours after the ingestion of contaminated meal up
to two days after suspension of feeding the diet [10].
Due to its high hepatocarcinogenic potential, the level of AFM1 permitted in milk and dairy
products is strictly regulated in the developed countries: the regulatory limit for AFM1 in milk and
dairy products is 50 ppt in European countries and 500 ppt in the United States. Furthermore, because
the biotransformation of carcinogens is generally slower in children than in adults, European Union
(EU) legislation on food contaminants [11] fixes a more restrictive limit (25 ppt) for milk intended for
consumption by nursing infants and children.
Robust analytical methods are needed to detect mycotoxins. The choice of which analytical process
is most appropriate will take into account the target molecule, chemical features, complex matrix,
timing of testing, and required limits of detection/quantification [12]. The methods for determining
AFM1 can be classified into two main groups: chromatographic and immunochemical.
Immunochemical methods are used for rapid screening of AFs in various sample matrices.
Several approaches have been developed for the determination of AFM1, but the method of choice
is dictated by the type of matrix (fresh, stored, pasteurized milk, liquid or powdered milk, cheese).
Many commercially available products use enzyme-linked immunosorbent assay (ELISA), TLC or
HPLC [13].
Generally, chromatographic methods require extensive sample preparation steps and well-trained
personnel; therefore, they are usually used for either confirmation of the results obtained from rapid
screening tests or for accurate quantitative determination of mycotoxins. Immunochemical methods
for rapid screening use specific antibodies with good sensitivity. Several immunochemical techniques,
including ELISA, immunoaffinity column assays (ICA), sequential injection immunoassay (SIIA), and
radioimmunoassay (RIA), have been developed for the determination of AFM1 in milk.
Here we describe the validation protocols for ELISA and HPLC tests for screening and
confirmatory detection, respectively, of AFM1 levels in milk. ELISA was validated for use as a
qualitative (screening) approach and HPLC as a quantitative (confirmatory) approach. Performance
was evaluated on artificially spiked milk samples. Furthermore, the aim of the study was also to
analyze a large number of milk samples from North Italy during 2012–2014. Finally, we wanted
to determine whether the differences in AFM1 levels correlated with climatic conditions (i.e., mean
temperature, humidity rate, and precipitation) known to be risk factors for AF contamination of silage.
2. Results
2.1. Validation of ELISA
ELISA performance and efficiency were evaluated. Analysis of specificity showed that the β
error was ď5%, confirming that the test is able to discriminate the analyte. The different incubation
temperatures had no significant effect on assay performance, indicating that the test is sufficiently
rugged. Finally, sensitivity was 1.00 (95% confidence interval CI 0.91–1.00).
2.2. Validation of HPLC
The HPLC method was in good agreement with the criteria stated in Commission Regulation
(EC) No. 401/2006 [14]. The method was linear in the range of 0.75–25 ppb (pg/µL), corresponding
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to 0.006–0.2 ppb in matrix, indicating no interference by the food matrix and acceptable specificity.
The tests to check repeatability and recovery are reported in Table 1 and were considered satisfactory
according to internal requirements and parameters.
Table 1. Repeatability and recovery data.
Parameters
AFM1 Spike Doses
0.025 ppb 0.050 ppb 0.075 ppb
Repeatability (Coefficient of variation CV%) 9.7 7.6 7.0
Recovery (% ˘standard deviation SD) 95 ˘ 7.8 93 ˘ 5.8 96 ˘ 5.8
The limit of detection (LOD) and quantification (LOQ) were 0.002 ppb and 0.010 ppb, respectively.
Method ruggedness was satisfactory at the tested conditions. Stability tests confirmed that stock
solutions are stable at ´18 ˝C for 18 months. Finally, method uncertainty was 13%.
Figure 1 shows the curve built for the validation protocol: the R2 was >0.99. This value needs to
be reached in any analytical session in order to consider the test results acceptable.
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2.3. Results of Sample Analysis
Between 2012 and 2014, a total of 1668 milk samples (548 in 2012; 625 in 2013; 495 in 2014) were
collected throughout northwest Italy and delivered to the Milk Laboratory of the Istituto Zooprofilattico
Sperimentale del Piemonte, Liguria and Valle d’Aosta (IZSTO) in Turin. Table 2 lists the surveys during
which samples were collected by official veterinary local health services and by IZSTO researchers for
study purposes.
Most samples, about 58% of the total number, were collected through the Raw Milk Automatic
Self-Service Vending Machines Survey (2012–2014) to monitor the presence of AFM1 in milk for
human consumption [15,16], followed by the Extraordinary Local Plan to survey AFM1 occurrence and
climatic conditions (10.8%), the National Plan for Residue Detection (10.7%), the Regional Food Safety
Plan (4.8%), the plan conducted on farms in compliance with Regulation EC 853/2004 requirements
(2.2%), and the surveys for import-export activities (1.3%).
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Table 2. Samples collected through official surveys in northwest Italy (2012–2014).
Purpose 2012(N = 548)
2013
(N = 625)
2014
(N = 495)
Total
(N = 1668) %
Raw Milk Vending Machine Survey 381 332 255 968 58.0
Study Purposes 6 35 142 183 11.0
Extraordinary AFM1 Local Survey 31 116 33 180 10.8
National Residues Plan 57 85 37 179 10.7
Regional Food Safety Survey 52 14 14 80 4.8
Tank Milk Survey
(Regulation EC 853/2004) 3 31 3 37 2.2
Import-Export Survey 7 9 5 21 1.3
Other 11 3 6 20 1.2
Of the total of 1,668 samples, 36 (2.2%) were found positive by ELISA and confirmed by HPLC
(Table 3). According to the maximum acceptable limit fixed by European legislation, only eight samples
were noncompliant (AFM1 levels >50 ppt). For these samples, quantitative HPLC showed a range in
AFM1 from 74 ˘ 10 ppt to 208 ˘ 27 ppt (last column in Table 3).
Table 3. Aflatoxin M1 levels in milk samples.
Survey Year
Number of
Samples
(N = 1668)
Positive
Samples
(ELISA/HPLC)
(N = 36)
Positive
Samples (%)
(% = 2.2)
Noncompliant
with EU Limit
(N = 8)
Noncompliant
with EU
Limit (%)
(% = 0.5)
AFM1 Level in
Noncompliant
Samples (ppt) 1
2012 548 11 2.0 4 0.7
74 ˘ 10
83 ˘ 11
89 ˘ 12
208 ˘ 27
2013 625 22 3.5 4 0.6
86 ˘ 11
98 ˘ 13
137 ˘ 18
195 ˘ 25
2014 495 3 0.6 0 0.0 -
1 Data reported as concentration ˘ measurement uncertainty.
Of these eight noncompliant samples, four were collected in 2012 and four in 2013: five samples
were collected through the Raw Milk Vending Machines Survey, two through the Extraordinary AFM1
Survey, and one through the National Residues Plan. For the year 2012, four samples with AFM1
levels >50 ppt were collected: one in October and three in November; for the year 2013, two samples
were collected in February and one each in May and July. All noncompliant samples were attributable
to summer 2012 (t = 2.4; p = 0.04), whereas no statistical difference was detected between AFM1
concentrations (mean concentration 53.8 in 2012 vs. 43 in 2013).
Environmental conditions such as high humidity and drought promote AFB1 contamination
in maize. Because these conditions predominate during summer in northwest Italy, farmers should
make efforts to limit maize stress and Aspergillus development. Irrigation and fertilization are used
to minimize the effect of drought and nutrition stress, respectively. Unfortunately, heat remained a
major uncontrolled source of stress, although other unrecognized sources of stress may also have
been present [17]. Average temperature, humidity rate (%), and precipitation data are reported in
Figures 2–4 respectively. The bar graphs show the number of positive and noncompliant samples by
month of collection. Most positive samples (22/36; 61%) were collected between November 2012 and
May 2013.
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For statistical analyses, the AFM1-positive samples were divided into two groups: positive
milk samples collected September 2012 through August 2013 and assumed to be associated with the
climatic conditions of the previous summer (May–August 2012) (group 1), and, similarly, milk samples
collected September 2013 through August 2014 (group 2) (Table 4). This was done in order to account
for seasonal differences in climatic conditions across the two years: the average recorded temperature
(May–August) for the summer of 2012 was 21.7 ˝C and that for the summer of 2013 was 20.5 ˝C; the
precipitation index (mm) for the summer of 2012 was 117.5 mm and that for the summer of 2013 was
125.0 mm; finally, the relative humidity for the summer of 2012 was 64.4% and that for the summer of
2013 was 64.9%.
Table 4. Comparison between the number of AFM1-positive milk samples collected after the two
summer periods (May–August 2012 and May–August 2013).
Month Positive byELISA (N)
Non-Compliant
(N) Month
Positive by
ELISA (N)
Non-Compliant
(N)
September 2012 1 0 September 2013 2 0
October 2012 2 1 October 2013 0 0
November 2012 4 3 November 2013 0 0
December 2012 0 0 December 2013 0 0
January 2013 2 0 January 2014 0 0
February 2013 6 2 February 2014 0 0
March 2013 3 0 March 2014 0 0
April 2013 3 0 April 2014 0 0
May 2013 4 1 May 2014 0 0
June 2013 0 0 June 2014 1 0
July 2013 1 1 July 2014 0 0
August 2013 1 0 August 2014 0 0
Total (N) 27 8 Total (N) 3 0
Mean 2.25 0.7 Mean 0.25 0
There was a statistically significant difference in the number of ELISA positive samples/months
between the two groups (mean value 2.25 and 0.25, respectively; t = 3.6; p = 0.003); and all noncompliant
samples had been collected in the summer of 2012 (t = 2.4; p = 0.04).
3. Discussion
The cumulative data presented here originate from surveys conducted throughout northwestern
Italy between 2012 and 2014. Overall, the AFM1 contamination rate was 2.2% but less than 1% of
milk samples of the total number were noncompliant with the EU limit. Previous studies reported a
contamination rate of 14% in milk samples from southern Italy, though the AFM1 level was never above
the permitted EU limit (range 0 to 40 ppt) [18]. Annual surveys on goat and sheep milk in Sardinia
reported AFM1-positive rates of 0%–4% in sheep and 0%–13% in goat [19]. The low rates found for
northwest Italy can be explained as a result of the implementation of own-check analyses. Mandatory
for dairy cow milk producers, this system entails daily analyses of milk samples during high-risk
periods to alert for the presence of AFM1 when detected at concentrations above the permitted level.
If an alert has been signaled, the farmer must withdraw the products and suspend delivering milk
to market.
Unsurprisingly, 61.1% of the AFM1-positive samples were collected during the two periods,
November 2012–May 2013 and November 2013–May 2014, from cattle in northern Italy fed with maize
silage of the previous summer, a season known as important as a source of mycotoxins [20].
Similarly, other studies have shown that AFM1 contamination is more likely to occur in milk
produced during cold than warm seasons [21]. Bilandzic et al. (2010) observed that AFM1 concentration
in milk was statistically higher during winter and spring than summer and autumn [22]. According to
the weather records for our study area, the mean temperature was 21.7 ˝C and the rainfall amount was
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117.5 mm for the summer of 2012 (May through August), whereas the mean temperature was slightly
lower (20.5 ˝C) and rainfall was more abundant (125 mm) in 2013. Indeed, all noncompliant samples
were collected in the period immediately following the summer of 2012 (t= 2.4; p = 0.04), whereas no
statistical difference was detected between AFM1 concentrations (mean concentration 53.8 in 2012 vs.
43 in 2013).
Environmental conditions, such as temperature, humidity, and rainfall, as well as seasonal
effects play an important role in feed contamination with AFB1 [23–25]. Poor storage conditions and
practices during the ensiling process or when the silo is open for feeding can also lead to fungal
contamination [26]. For these reasons, the most effective method to control AFM1 concentration in
milk is by reducing the AFB1 contamination of raw materials and cattle feed through the application
of Good Agricultural and Storage Practices [27,28]. Mycotoxin control largely depends on taking
proper care during pre- and post-harvest conditions [29]. The use of fertilizers, pest controls, and
fungal-resistant crops, as well as maintaining low moisture content and temperature during storage
conditions can prevent fungal and mycotoxin contamination [30,31].
Because AFB1 contamination levels vary with year and climate, it may be useful to develop an
AFB1 monitoring program that takes into account climatic conditions and pre-harvest maize quality
during its growing season and that includes a specific survey on AFM1 detection in milk.
As concerns other matrices affected by AFs contamination, the HPLC method is more sensitive
and specific, whereas the ELISA technique is cheaper and easier in laboratory practices [32]. The
HPLC procedure is complicated and requires investment in expensive equipment and highly skilled
technicians [33]. However, HPLC and other chromatographic methodologies also offer the advantage
over ELISA techniques in that individual toxins can be quantified in the same analysis session [34].
The use of reliable and validated tests is essential for the official control of mycotoxin levels in food and
feed. By reviewing and validating new methods for the determination of AFM1, researchers continue
to refine extraction, purification, and quantification techniques in order to improve the reliability of the
results concerning the impact of this compound in milk and meet the current demand for minimum
waste generation. Evaluation of other techniques showed different sensitivity and specificity; however,
these studies did not carry out parallel validation protocols [13]. Furthermore, the use of two different
tests in series, as done in this study, underlines the useful features of both methods for providing
excellent laboratory performance. Also, this protocol enables the National Health Services to collect
and analyze large numbers of samples with high accuracy at reduced costs while ensuring analytical
results that are both highly sensitive and specific. Though ELISA-based techniques are useful for rapid
screening of mycotoxins, they can produce false-positive results and, on occasion, lack acceptable
quantification accuracy; quantitative confirmatory analysis is therefore required.
4. Experimental Section
4.1. Sample Collection
The milk samples were delivered to the Milk Laboratory at Istituto Zooprofilattico Sperimentale
del Piemonte, Liguria and Valle d’Aosta to determine the AFM1 level. These samples were collected
throughout northwestern Italy (Figure 5) by the veterinary services of local health authorities for
official controls and surveys and by IZSTO researchers for study purposes.
Toxins 2016, 8, 57 8 of 12
Toxins 2016, 8, 57 
8 
 
Figure 5. Spatial distribution of sampling sites. 
All samples were stored at 4 ± 2 °C until analysis within 24–48 h. An aliquot of each sample was 
frozen for use in other studies. 
4.2. ELISA Screening 
All  samples  were  processed  using  a  commercial  competitive  ELISA  test  (RIDASCREEN® 
Aflatoxin M1, R‐Biopharm, Darmstadt, Germany)  in  a  semi‐quantitative method. As  directed,  a 
volume of 12 mL of milk was skimmed by centrifugation (3500 g for 10 min at +2/+8 °C) and the fat 
layer removed. ELISA plates were prepared with standards, samples, and a negative control. The 
negative control was a milk sample that resulted negative by HPLC; a positive control was a milk 
sample artificially spiked with 0.05 ppm AFM1. A volume of 100 μL standard/sample was transferred 
into the well and incubated for 45 min at 20–25 °C. Liquid was discarded by capsizing the plate. Each 
well was washed 4  times with 250 μL of wash buffer supplied with  the kit. Hereafter, 100 μL of   
AF‐HPR (human haptoglobin‐related protein) conjugate were added to each well; after incubation 
(15 min at 20–25 °C), the plate was washed 4 times with 250 μL wash buffer. A volume of 100 μL 
aflatoxin‐HPR conjugate was dispensed in each well, and the plate was gently shaken and incubated 
(15 min at 20–25 °C). Finally, a volume of 50 μL stop buffer supplied with the kit was pipetted into 
each well, and the plate was read at 450 nm.   
The tabulated OD values were entered in the R‐Biopharm spreadsheet. Each analytical session 
reported the respective calibration curve for OD% values of samples and controls to quantify AFM1 
levels. This  test was used solely as a qualitative method: samples with AFM1 values ≥5 ppt were 
labeled  “suspected positive”  and processed by  confirmatory HPLC.  Samples with values  <5 ppt 
(LOD) were considered ʺnegativeʺ. 
4.3. HPLC Confirmatory Method 
Sample preparation entailed a purification phase using 50 g of milk, previously skimmed by 
centrifugation at 3756 g  for 15 min at 5 °C with  immuno‐affinity chromatography columns  (IAC)   
(R‐Biopharm AG, Darmstadt, Germany). First, the well was loaded with the sample and washed with 
50 mL water.  The  analyte was  eluted with  2 mL  acetonitrile‐methanol mixture  (60:40  v/v).  The 
flowthrough was dried with a nitrogen stream at 50 °C and suspended with 200 μL acetonitrile‐methanol 
mixture (60:40, v/v) and 200 μL water. The suspension was then filtered on a 0.2 μm membrane filter. 
Figure 5. Spatial distribution of sampling sites.
All samples were stored at 4 ˘ 2 ˝C until analysis within 24–48 h. An aliquot of each sample was
frozen for use in other studies.
4.2. ELISA Screening
All samples were processed using a commercial competitive ELISA test (RIDASCREEN®Aflatoxin
M1, R-Biopharm, Darmstadt, Germany) in a semi-quantitative method. As directed, a volume of 12 mL
of milk was skimmed by centrifugation (3500 g for 10 min at +2/+8 ˝C) and the fat layer removed.
ELISA plates were prepared with standards, samples, and a negative control. The negative control
was a milk sample that resulted negative by HPLC; a positive control was a milk sample artificially
spiked with 0.05 ppm (mg/kg) AFM1. A volume of 100 µL standard/sample was transferred into the
well and incubate for 45 min at 20–25 ˝C. Liquid was discarded by capsizing the plate. Each well was
washed 4 times with 250 µL of wash buffer supplied with the kit. Hereafter, 100 µL of AF-HPR (human
haptoglobin-related protein) conjugate wer added to each well; after incubation (15 min at 20–25 ˝C),
the plate was washed 4 imes w th 250 µL w s buffer. A volume of 100 µL aflatoxi -HPR onjugate
was dispensed in each well, and the plate was gently shaken and incubated (15 min at 20–25 ˝C).
Fin lly, a volume of 50 µL stop buffer supplied with the kit was pipetted into each well, and the plate
was read at 450 nm.
The tabulated OD values were entered in the R-Biopharm spreadsheet. Each analytical session
reported the respective calibration curve for OD% values of samples and controls to quantify AFM1
levels. This test was used solely as a qualitative method: samples with AFM1 values ě5 ppt were
labeled “suspected positive” and processed by confirmatory HPLC. Samples with values <5 ppt (LOD)
were considered “negative”.
4.3. HPLC Confirmatory Method
To confirm ELISA positive samples a HPLC method [35] was used and each sample was analyzed
with two replicates. Sample preparation entailed a purification phase using 50 g of milk, previously
skimmed by centrifugation at 3756 g for 15 min at 5 ˝C with immuno-affinity chromatography
columns (IAC) (R-Biopharm AG, Darmstadt, Germany). First, the well was loaded with the sample
and washed with 50 mL water. The analyte was eluted with 2 mL acetonitrile-methanol mixture
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(60:40 v/v). The flowthrough was dried with a nitrogen stream at 50 ˝C and suspended with 200 µL
acetonitrile-methanol mixture (60:40, v/v) and 200 µL water. The suspension was then filtered on a
0.2 µm membrane filter. The chromatographic system was composed of an HPLC chromatograph
system (Agilent 1200 series, Agilent Technologies, Santa Clara, CA, USA) with fluorimetric detection
(FLD), λexcitation = 360 nm, λemission = 430 nm, column LiChrospher 60 RP SELECT B (Merck,
Darmstadt, Germany) (250ˆ 4.6 mm, 5 µm) at 35 ˝C, isocratic elution with water-acetonitrile-methanol
mixture (65:15:20, v/v/v), flow rate 1 mL/min, and injection volume 20 µL.
4.4. Validation of ELISA
The ELISA method was validated according to Commission Decision 2002/657/CE [36]
concerning the performance of analytical methods and the interpretation of results. The protocol
includes the following parameters: method specificity, ruggedness, sensitivity. Specificity was
determined on 20 negative milk samples and 20 milk samples spiked with 40 ppt AFM1. To evaluate
method ruggedness, the influence of 2 different incubation temperatures (25 ˝C and 30 ˝C) was
evaluated with the approach of Youden [37]. Sensitivity was determined by testing 26 negative
samples (<40 ppt) and 38 positive samples (>40 ppt) and was calculated using EpiTools epidemiological
calculators: [38].
4.5. Validation of HPLC
The HPLC method was validated according to Commission Regulation (EC) No. 401/2006 [15].
Specificity was determined on 20 milk samples (range ∆t = Rt ˘ 2.5%); linearity was calculated with a
calibration curve by injection of standard in solvent at 0.8–25 ppb; precision was determined on milk
samples spiked with 0.025–0.050–0.075 ppb or 0.5–1–1.5 times the permitted EU limit (0.050 ppb).
Each level of concentration was measured independently in 6 repeats. In each session,
coefficient of variation (CV%) of repeatability for each level was calculated using analysis of variance
(ANOVA) [39]; recovery was tested by external standardization and calculated as the average recovery
for each level of concentration; limit of detection (LOD) and limit of quantification (LOQ) were
calculated on 20 milk positive samples, in application of Regulation EC 401/2006; ruggedness was
evaluated according to Youden’s index [37] and 8 experiments were performed on milk samples spiked
with 0.050 ppb, introducing small changes during sample preparation and analysis. The variables
were: IAC column type, IAC column washing buffer, elution volume, evaporation temperature,
period, centrifugation speed and temperature; stability was determined by conservation at ´18˝C
for 18 months of acetonitrile stock solution; finally, measurement of uncertainty was calculated by a
bottom-up method [40] using coverage factor K = 2 and n = 2. Finally, 2 samples spiked with 0.05 ppb
AF were tested in each analysis session in order to verify the accuracy and repeatability of analysis,
following recovery control charts.
4.6. Statistical Analyses
Statistical analyses were performed using SPSS version 11.0 (SPSS Inc, Chicago, IL, USA, 2002).
The number of positive samples/month among the samples attributable to silages prepared in summer
2012 was compared with those attributable to summer 2013. A similar analysis was performed on the
number of noncompliant samples/month and the mean AF level in positive samples. After checking
for the assumption of normality and homogeneity of variances, comparisons were performed using a
t-test for unequal variances. Results with p < 0.05 were considered statistically significant.
5. Conclusions
The two methods validated in this study demonstrated good performance, being able to meet EU
regulatory requirements and to detect AFM1 at the limits fixed by European legislation [15]. Ideally,
a complete survey is based on screening and confirmatory testing of large numbers of samples. In
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this study, the use of ELISA for screening yielded rapid results with high sensitivity; subsequent
confirmation by HPLC was particularly useful to detect the noncompliant milk samples.
The contamination rate (2.2%) in the milk samples indicates that AFM1 continues to pose a risk
for human health; nevertheless, less than 1% of the samples had an AFM1 level >50 ppt. The permitted
limits set by EU legislation are derived from studies on the effects of long-term exposure to AFM1, and
this is to be considered as further protection for consumer safety [14].
The daily mean temperature during the maize-growing season was statistically correlated with
the number of noncompliant milk samples, as all of them were collected in the summer of 2012.
Monitoring temperature and humidity conditions may help to predict increases in AF content in feed
and AFM1 levels in milk. Sampling plans carried out in Europe and Italy continuously monitor AFM1
levels in milk. The construction of databases can be a useful step to identify changes in AF levels in
food for human and animal use and to manage possible emergencies that may occur.
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Abbreviations
CI Confidence Interval
EC European Commission
ELISA Enzyme-Linked ImmunoSorbent Assay
FLD fluorometric detection
HPLC High-Performance Liquid Chromatography
ppm parts per million corresponding to mg/kg
ppb parts per billion corresponding to µg/kg
ppt parts per trillion corresponding to ng/kg
LOD Limit of Detection
LOQ Limit of Quantification
TLC Thin-layer chromatography
UV Ultraviolet
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